Fellow’s Column: A Neonate with Recurrent Apnea

Daniel Farishta, MD, Briana Hernandez, MD, Shabih Manzar, MD

Summary:

We describe a case of a newborn infant who developed significant apnea, bradycardia, and desaturation (ABDs) at 35 weeks postmenstrual age (PMA). On the day of life 37 (39 2/7 PMA), an otolaryngology evaluation showed edematous floppy arytenoids prolapsing into the airway. The infant underwent a carbon dioxide (CO2) laser supraglottoplasty. After surgery, the infant continued to nipple well with no further episodes of ABD and was discharged home in stable condition. At the follow-up visit on the day of life 59, she was asymptomatic and growing well. CO2 laser supraglottoplasty successfully cured the infant’s life-threatening events and resulted in her discharge, decreasing the length of her hospital stay and alleviating parental anxiety.

Case:

The infant was born at a gestational age of 34 weeks. Soon after birth, she had signs of respiratory distress syndrome, for which she was intubated orally with a 3.5 mm endotracheal tube without difficulty, was given one dose of surfactant, and was placed on a ventilator. At 19 hours of life, she was extubated successfully to a high-flow nasal cannula. By day 3 of life, she was stable in room air and tolerating oral feedings. Parents were counseled, and discharge planning started.

On the night before the planned discharge day, the infant devel- oped significant apnea, bradycardia, and desaturation (ABD). A complete workup showed normal hemoglobin, head ultrasound, echocardiogram, and video electroencephalogram. As per unit protocol, a 5-day observation was started. Once again, on the night before discharge, the infant had significant ABD requiring stimulation. The pattern of ABD and 36-week postmenstrual age (PMA) was not suggestive of central apnea, so treatment with caffeine was not considered. As the infant had no respiratory distress except for 1-2 episodic ABD at night, we did not try nasal continuous positive airway pressure (CPAP) or nasal cannula and continued with a 5-day observation before discharging home. Multiple plans to discharge home failed due to significant ABDs at night. On the day of life 37 (39 2/7 weeks GA), an otolaryngology evaluation showed edematous floppy arytenoids prolapsing into the airway on a flexible nasolaryngoscopy. Figure 1 shows the anatomical landmark with a thickened aryepiglottic fold. On the day of life 39, the infant underwent a carbon dioxide (CO2) laser supraglottoplasty in the operating room. Figure 2 shows the aryepiglottic folds being clipped with microsurgical scissors. Figure 3 shows the lateral arytenoid complex after CO2 laser ablation. After the surgery, the infant was observed for ABDs for 48 hours. She continued to nipple well with no further episodes of ABD and was discharged home in stable condition on the day of life 42. At the follow-up visit on the day of life 59, she was asymptomatic and growing well.

The picture shows the anatomical landmark with thickened aryepiglottic fold

Figure 1: The picture shows the anatomical landmark with thickened aryepiglottic fold 

The aryepiglottic fold is identified and clipped with the
microsurgical scissors

Figure 2: The aryepiglottic fold is identified and clipped with the microsurgical scissors 

Status post-CO2 laser ablation of lateral arytenoid complex

Figure 3: Status post-CO2 laser ablation of lateral arytenoid complex 

Discussion: 

In the case described, the infant did not have any stridor but significant ABD due to the floppy arytenoids. In a previous report by Lis et al. (1), floppy arytenoid cartilages were noted as a common cause of stridor in infants. Temper et al. (2) described a similar case, but the infant had significant stridor. 

Preterm infants are prone to laryngomalacia (LM) that does not necessarily present soon after birth, and symptoms can take a few days or weeks. (3) Prematurity may predispose infants to unusual presentations of LM, including apneic events with no observed stridor. In most cases, it resolves with time, but 20% of infants with LM present with severe disease requiring surgery to eliminate or bypass the obstruction, as seen in the case presented. A success rate of 94% with minimal risk of recurrent symptoms or complications has been reported.(4) Katin and Tucker (5) described a case series of laryngomalacia in young children treated with CO2 laser to vaporize excess floppy supra-arytenoid tissue. 

We did not perform polysomnography, as evidence showed it to be a low-value investigation and did not correlate with the clinical severity and need for surgery. (6 ) As noted in the case description, we did not institute a trial of caffeine or CPAP due to the episodic nature and gestational maturity. Surgical intervention was performed, as further delaying surgery would have increased the hospital stay. 

In conclusion, CO2 laser supraglottoplasty successfully cured the infant’s life-threatening events and resulted in her discharge, decreasing the length of her hospital stay and alleviating parental anxiety. 

References: 

  1. Lis G, Szczerbinski T, Cichocka-Jarosz E. Congenital stridor. Pediatr Pulmonol. 1995;20(4):220-224. doi:10.1002/ppul.1950200404 
  2. Templer J, Hast M, Thomas JR, Davis WE. Congenital laryngeal stridor secondary to flaccid epiglottis, anomalous accessory cartilages and redundant aryepiglottic folds. Laryngoscope. 1981;91(3):394-397. doi:10.1288/00005537-198103000-00008 
  3. Leonard JA, Reilly BK. Laryngomalacia in the Premature Neonate. Neoreviews. 2021;22(10):e653-e659. doi:10.1542/ neo.22-10-e653 
  4. Richter GT, Thompson DM. The surgical management of laryngomalacia. Otolaryngol Clin North Am. 2008;41(5):837- vii. doi:10.1016/j.otc.2008.04.01 
  5. 5. Katin LI, Tucker JA. Laser supraarytenoidectomy for laryngomalacia with apnea. Trans Pa Acad Ophthalmol Otolaryngol. 1990;42:985-988. 
  6. 6. McCaffer C, Blackmore K, Flood LM. Laryngomalacia: is there an evidence base for management? J Laryngol Otol. 2017;131(11):946-954. doi:10.1017/S0022215117002092 

Discolosure: The authors have no competing interests to declare. 

Daniel Farishta, MD

Daniel Farishta, MD
Resident PGY-3
Department of Otolaryngology Head & Neck Surgery
LSU Health Sciences Center
1501 Kings Highway
Shreveport, LA 71103

Briana Hernandez, MD

Briana Hernandez, MD
Resident PGY-1
Department of Pediatric
LSU Health Sciences Center
1501 Kings Highway
Shreveport, LA 71103

Corresponding Author
Shabih Manzar, MD

Shabih Manzar, MD
Clinical Associate Professor
LSU Health Sciences Center
1501 Kings Highway
Shreveport, LA 71103
Telephone: 318-626-1623
Fax: 318-675-6059
Email: shabih.manzar@lsuhs.edu

Fellow’s Column is published monthly. 

Submission guidelines for “Fellow’s Column”: 

  • 2000 word limit not including references or title page. Exceptions will be made on a case by case basis 
  • QI/QA work, case studies, or a poster from a scientific meeting may be submitted.. 
  • Submission should be from a medical student, resident, fellow, or NNP in training. 
  • Topics may include Perinatology, Neonatology, and Younger Pediatric patients. 
  • No more than 20 references. 

Please send your submissions to: 

Elba Fayard, MD, Interim Fellowship Column Editor 
or Japmeet Sandhu, OMS IV Fellowship Column Assistant Editor 
LomaLindaPublishingCompany@gmail.com